Article
Immunoregulatory T cells in cancer immunotherapy.
Expert opinion on biological therapy - 1 Dec 2002
Morse Michael A, Clay Timothy M, Mosca Paul, Lyerly H Kim
Abstract excerpt
Many of the tumour antigens targeted by active immunisation strategies are in fact self-antigens. Successful anticancer immunotherapy will therefore require not only potent methods of T cell activation, but also successful interference with mechanisms of immune tolerance that have evolved to prevent tissue destruction by autoreactive T cells. In addition to thymic deletion, anergy and skewing of T cell cytokine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
